0 Commentarii
0 Distribuiri
580 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Rising Adoption of ICDs and Genetic Testing Drives Brugada Syndrome Market, Led by Biotronik, MicroPort Scientific Corporation, and LivaNovaThe global Brugada Syndrome market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.8 billion by the end of 2034, growing at a CAGR of 7.8% from 2024 to 2034. Market growth is driven by increasing awareness of rare cardiac disorders, advancements in diagnostic technologies, and rising adoption of implantable cardioverter defibrillators (ICDs) and genetic testing for early...0 Commentarii 0 Distribuiri 6 Views 0 previzualizare